Foamix Ltd. and Therapeutics Inc. Enter into Joint Venture to Develop New Prescription Foams for Inflammatory Skin Diseases

US Grant for Foamix's Saccharide Foam Patent - Topical "Sweet Foam" Products for Wound & Burn Therapy

Foamix is a Finalist for the Red Herring 100 Global Award for Most Promising Technology Ventures

Dermatology co Foamix teams with Switzerland's Galderma

Foamix Expands International Patent Protection for its Emollient Foam Platform

Foamix Extends Collaboration with Galderma

Foamix Ltd. and VIB Sign Co-Development Agreement for Innovative Topical Therapy for Psoriasis

Promius Pharma, LLC Launches Scytera™ (Coal Tar) Foam 2% for Treatment of Psoriasis

Foamix is Finalist for International 2008 SCRIP Award

Ferndale and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis

Omnibus Survey:72% of Women Are Dissatisfied with Their Current Treament of Vaginal Infection

Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases

Foamix is a finalist for the Red Herring 100 Europe 2008 Award

BIRD invests $14m in 16 joint projects; English Hebrew

Foamix Announces New Foam Patent Approvals

Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis

Foamix Acquires Rights to Dual Chamber Aerosol Foam Technology

In-Pharma Technologist.com: Best Foam Forward

Foamix presents Innovative Intra-Vaginal Foam Delivery for Gynecology

Foamix Signs R&D Collaboration and License Agreement with Dr. Reddy’s for the Development and Commercialization of Psoriasis Foam

YNET: Collaboration with Warner Chilcott on gynecologic treatment (article in Hebrew)

Warner Chilcott and Foamix Collaborate on Gynecologic Foam Product

Foamix and Intendis Sign License Agreement for the Development of a Dermatological Foam

Globes: Foamix collaborates with Warner Chilcott on acne treatment

Warner Chilcott and Foamix Collaborate on Foam Product for the Treatment of Acne


 
Featured Cosmetic Product Pipeline

  • Emollient Day Mousse
    • Foamix Day Mousse is a foam version of currently used moisturizing cream. It is easily spread on the face and large body surfaces with rapid absorption.
    • Proven skin-moisturizing effect for 24 hours.
    • The Foamix Emollient Foam is non-irritating and hypoallergenic, as demonstrated in controlled human studies. It is composed of delicate cosmetic excipients, to provide a very gentle skin care product.
       
  • Intensive Night Mousse
    • Foamix Night Mousse is a foam version of currently used intensive moisturizing cream.
    • Proven skin-moisturizing effect for 24 hours.
    • The Foamix Emollient Foam is non-irritating and hypoallergenic, as demonstrated in controlled human studies. It is composed of delicate cosmetic excipients, to provide a very gentle skin care product.
       
  • FoamixWhite™
    • Foamix-White™ is an elegant, easy to use, delicate cosmeceutical foam for the treatment of hyperpigmentation and age spots.
         
  • Foot Foam™.
    • Highly moisturizing, alcohol-free foam product for the treatment of dry, scaly skin of the foot.
         
  • BabyFoamix™ Zinc
    • BabyFoamix™ Zinc is an easy to use protective foam for the prevention and treatment of diaper rash. It contains an optimal combination of protective and occlusive oil substances and Zinc Oxide.
    • BabyFoamix™ Zinc is non-irritating, as demonstrated in controlled human studies.
      •  
  • BabyFoamix™ Oil
    • BabyFoamix™ Oil provides an innovative presentation for the traditional baby oil. It is drip-free and easy to use.
    • BabyFoamix™ Oil is non-irritating, as demonstrated in controlled human studies.
      •  
  • BabyFoamix™ Emollient
    • BabyFoamix™ Emollient provides an innovative presentation for the traditional baby lotion.